GlassScriptAvertix Medical, INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$355Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
15clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Kevin Campbell | Melbourne, FL | Cardiovascular Disease | $71,588.09 |
| Mitchell Krucoff | Durham, NC | Cardiovascular Disease | $63,250.00 |
| Andrew Kaplan | Mesa, AZ | Cardiovascular Disease | $61,419.80 |
| Charles Gibson | Boston, MA | Interventional Cardiology | $60,000.00 |
| Usman Siddiqui | Winter Park, FL | Clinical Cardiac Electrophysiology | $32,965.00 |
| Tim Fischell | Kalamazoo, MI | Interventional Cardiology | $24,210.03 |
| Leon Feldman | Rancho Mirage, CA | Clinical Cardiac Electrophysiology | $15,630.00 |
| Brian Kolski | Orange, CA | Interventional Cardiology | $12,728.10 |
| Suresh Rao | Los Angeles, CA | Cardiovascular Disease | $6,390.00 |
| Arthur Eberly | Greenville, SC | Cardiovascular Disease | $2,070.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.